CoChat

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Burden of allergic respiratory disease: a systematic review

Open access
Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., Boxall, N. · 2016 · Clinical and Molecular Allergy

Abstract

This meta-analysis compared the health-related quality of life (HRQL) of patients with allergic rhinitis (AR) and/or allergic asthma (AA) caused by perennial house dust mite (HDM) versus AR and/or AA caused by seasonal pollen allergy. Following a systematic search, the identified studies used the disease-specific rhinitis quality of life questionnaire or generic instruments (SF-36 and SF-12). Summary estimates obtained by meta-analysis showed that HRQL in patients with perennial HDM allergy was significantly worse than that of patients with seasonal pollen allergy, when measured by both disease-specific and generic HRQL instruments, and was reflected by an impact on both physical and mental health. A systematic review of cost data on AR and AA in selected European countries demonstrated that the majority of the economic burden was indirectly caused by high levels of absenteeism and presenteeism; there was little or no evidence of increasing or decreasing cost trends. Increased awareness of the detrimental effects of AR and/or AA on patients' HRQL and its considerable cost burden might encourage early diagnosis and treatment, in order to minimize the disease burden and ensure beneficial and cost-effective outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12948-016-0049-9

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic diagram of the selection process. Asterisk comparator not of interest = environmental control mechanisms, such as mattress protector or humidifier
Fig. 1 Schematic diagram of the selection process. Asterisk comparator not of interest = environmental control mechanisms, such as mattress protector or humidifierCC BY · PubMed Central
Fig. 2 Forest plot of overall RQLQ baseline scores by phenotype, from 30 groups in 15 studies. Higher scores indicate poorer HRQL
Fig. 2 Forest plot of overall RQLQ baseline scores by phenotype, from 30 groups in 15 studies. Higher scores indicate poorer HRQLCC BY · PubMed Central
Fig. 3 Forest plot of baseline SF-36/SF-12 physical component scores from 17 groups in six studies by phenotype. 95 % confidence intervals for the Mixed and PAR summary measures are hidden by the symbols. Lower scores indicate poorer HRQL
Fig. 3 Forest plot of baseline SF-36/SF-12 physical component scores from 17 groups in six studies by phenotype. 95 % confidence intervals for the Mixed and PAR summary measures are hidden by the symbols. Lower scores indicate poorer HRQLCC BY · PubMed Central
Fig. 4 Forest plot of baseline SF-36/SF-12 mental component scores by phenotype, from 17 groups in six studies. 95 % confidence intervals for the Mixed and PAR summary measures are hidden by the symbols. Lower scores indicate poorer HRQL
Fig. 4 Forest plot of baseline SF-36/SF-12 mental component scores by phenotype, from 17 groups in six studies. 95 % confidence intervals for the Mixed and PAR summary measures are hidden by the symbols. Lower scores indicate poorer HRQLCC BY · PubMed Central
Fig. 5 Overall RQLQ and SF-36 physical and mental component scores for the PAR and SAR phenotypes. a RQLQ scores of the PAR and SAR phenotypes; b left quality of life (QoL) measured by PCS of PAR and SAR patients. Right QoL measured by MCS of PAR and SAR patients. Error bars represent 95 % CI. Higher RQLQ scores and lower SF-36 scores indicate lower HRQL
Fig. 5 Overall RQLQ and SF-36 physical and mental component scores for the PAR and SAR phenotypes. a RQLQ scores of the PAR and SAR phenotypes; b left quality of life (QoL) measured by PCS of PAR and SAR patients. Right QoL measured by MCS of PAR and SAR patients. Error bars represent 95 % CI. Higher RQLQ scores and lower SF-36 scores indicate lower HRQLCC BY · PubMed Central
Fig. 6 RQLQ and SF-36 domain scores. a RQLQ domain scores in the combined PAR/SAR population; b SF-36 domain scores in the PAR/SAR population
Fig. 6 RQLQ and SF-36 domain scores. a RQLQ domain scores in the combined PAR/SAR population; b SF-36 domain scores in the PAR/SAR populationCC BY · PubMed Central
Fig. 7 Range of EQ-5D utility index scores for selected chronic conditions. Green and red circles represent the upper and lower values, respectively. Values were obtained from published studies in populations with cancer [82], psoriasis [82], cardiovascular diseases [82], visual disorders [82], type-2 diabetes mellitus [82], end stage renal disease [82], epilepsy [83], AR/HDM or AR and AA [23, 84], migraine [84] or chronic migraine [85], liver disease [82], and active psychoses [84, 86]. Lower EQ-5D values indicate lower HRQL
Fig. 7 Range of EQ-5D utility index scores for selected chronic conditions. Green and red circles represent the upper and lower values, respectively. Values were obtained from published studies in populations with cancer [82], psoriasis [82], cardiovascular diseases [82], visual disorders [82], type-2 diabetes mellitus [82], end stage renal disease [82], epilepsy [83], AR/HDM or AR and AA [23, 84], migraine [84] or chronic migraine [85], liver disease [82], and active psychoses [84, 86]. Lower EQ-5D values indicate lower HRQLCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Research works printed but not linked: 1

  1. Mosbech H. A phase II–III trial assessing the efficacy and safety of three doses of the ALK house dust mite tablet in house dust mite-allergic subjects 81 centres in DE, DK, ES, FR, GB, IT, PL, SE. Copenhagen: National University Hospital; 2009. p. 199.

Cited by

See all 155

Metadata

Authors
Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., & Boxall, N.
Affiliations
  • University of Copenhagen (DK)
  • ALK-Abelló (Denmark) (DK)
Corresponding author
Linneberg, A.
Venue
Clinical and Molecular Allergy
Published
2016-09-28
Volume
14
Issue
1
Pages
12-12
ISSN
1476-7961 (ISSN-L)
OpenAlex
W2526022291
Cited by
151
References
90
Citations by year
2026: 8 · 2025: 14 · 2024: 14 · 2023: 8 · 2022: 16 · 2021: 26 · 2020: 16 · 2019: 16 · 2018: 17 · 2017: 14 · 2016: 2
FWCI
2.42
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical and Molecular Allergy (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • VBN Forskningsportal (Aalborg Universitet) (submittedVersion, cc-by)
Funders
ALK, Hørsholm, Denmark
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Indoor Air Quality and Microbial Exposure
Keywords
allergic rhinitis, allergic asthma, house dust mite allergy, health-related quality of life, economic burden, absenteeism, presenteeism, disease burden, SF-36, SF-12

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Burden of allergic respiratory disease: a systematic review. https://app.cochat.ai/papers/10.1186/s12948-016-0049-9
The paper
Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., & Boxall, N. (2016). Burden of allergic respiratory disease: a systematic review. Clinical and Molecular Allergy. https://doi.org/10.1186/s12948-016-0049-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.